Track the 에이비온 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에이비온 has recorded 4 insider filings. Market capitalisation: €70.4bn. The latest transaction was disclosed on 6 July 2026 (Other). Among the most active insiders: 우성윤. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Listed on the XKRX market, 에이비온 is a company in the health and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.